Sign in

CIK 0001133869

  • Non-accelerated filer
  • Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 310-358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-25 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise +24,100 $3.18 $77K 35,323
2026-06-25 Bergmann Anthony CHIEF FINANCIAL OFFICER Sale −24,100 $30.38 $732K 11,223
2026-06-25 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise · Stock Option (Right to Buy) −24,100 91,980
2026-06-24 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise +400 $3.18 $1K 11,623
2026-06-24 Bergmann Anthony CHIEF FINANCIAL OFFICER Sale −400 $30.00 $12K 11,223
2026-06-24 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise · Stock Option (Right to Buy) −400 116,080
2026-06-22 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise +500 $3.18 $2K 11,723
2026-06-22 Bergmann Anthony CHIEF FINANCIAL OFFICER Sale −500 $30.00 $15K 11,223
2026-06-22 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise · Stock Option (Right to Buy) −500 116,480
2026-05-18 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise +3,000 $1.39 $4K 11,223
2026-05-18 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise · Stock Option (Right to Buy) −3,000 0
2026-05-01 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise 10b5-1 +25,000 $3.18 $80K 33,223
2026-05-01 Bergmann Anthony CHIEF FINANCIAL OFFICER Sale 10b5-1 −25,000 $31.70 $793K 8,223
2026-05-01 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 116,980
2026-03-31 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise 10b5-1 +25,000 $3.18 $80K 33,223
2026-03-31 Bergmann Anthony CHIEF FINANCIAL OFFICER Sale 10b5-1 −25,000 $30.13 $753K 8,223
2026-03-31 Bergmann Anthony CHIEF FINANCIAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 141,980
2026-01-05 Bergmann Anthony CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +25,000 25,000
2026-01-05 Bergmann Anthony CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +25,000 25,000
2026-01-05 Bergmann Anthony CHIEF FINANCIAL OFFICER Grant or award · Restricted Stock Units +2,500 2,500

Page 1 of 3 · 52 trades